Pharma Journalist - Page 681 of 834 -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

GlycoMimetics unveils design of Phase 3 Clinical Trial for GMI-1271 in Relapsed AML

FDA approves IND application for Moleac’s Phase 1 study MLC1501

Prometic receives Rare Pediatric Disease Designation from FDA

Vanda Pharmaceutical’s HETLIOZ for symptoms of jet lag disorder

MyBiotics signs second option agreement with Ferring Holding for the validation

Benitec Biopharma initiates Phase 2 Oncology Study in Australia

Trovagene confirms enrollment of First patient for Cycle 1 Treatment with PCM-075